Compare MLCI & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MLCI | BTMD |
|---|---|---|
| Founded | N/A | 2012 |
| Country | United States | United States |
| Employees | 21 | N/A |
| Industry | Investment Managers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.6M | 72.7M |
| IPO Year | N/A | 2021 |
| Metric | MLCI | BTMD |
|---|---|---|
| Price | $3.17 | $1.94 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $2.83 |
| AVG Volume (30 Days) | 25.1K | ★ 216.3K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.63% | N/A |
| EPS Growth | N/A | ★ 722.22 |
| EPS | N/A | ★ 0.06 |
| Revenue | N/A | ★ $192,219,000.00 |
| Revenue This Year | N/A | $2.03 |
| Revenue Next Year | N/A | $6.58 |
| P/E Ratio | ★ N/A | $33.58 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.14 | $1.27 |
| 52 Week High | $8.68 | $4.75 |
| Indicator | MLCI | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 31.42 | 47.44 |
| Support Level | N/A | $1.97 |
| Resistance Level | $7.98 | $2.17 |
| Average True Range (ATR) | 0.21 | 0.14 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 1.28 | 33.82 |
Mount Logan Capital Inc operates as emerging asset management and investment firm focused on investing in public and private debt securities in the North American market. The Company's reporting segments include asset management and insurance. The asset management segment reflects the Company's historical operations through its subsidiaries, including ML Management, and the insurance segment represents Ability's operations. The Company through its subsidiaries, earns management and incentive fees and servicing fees for providing investment management, monitoring and other services to investment vehicles and advisers. The insurance business is operated by Ability. Ability's insurance business consists of premium revenue from long term care insurance policies.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.